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Summary
The protamines are a diverse family of small arginine-rich proteins that are synthesized in the
late-stage spermatids of many animals and plants and bind to DNA, condensing the spermatid
genome into a genetically inactive state. Vertebrates have from one to 15 protamine genes per
haploid genome, which are clustered together on the same chromosome. Comparison of
protamine gene and amino-acid sequences suggests that the family evolved from specialized
histones through protamine-like proteins to the true protamines. Structural elements present in
all true protamines are a series of arginine-rich DNA-anchoring domains (often containing a
mixture of arginine and lysine residues in non-mammalian protamines) and multiple
phosphorylation sites. The two protamines found in mammals, P1 and P2, are the most widely
studied. P1 packages sperm DNA in all mammals, whereas protamine P2 is present only in the
sperm of primates, many rodents and a subset of other placental mammals. P2, but not P1, is
synthesized as a precursor that undergoes proteolytic processing after binding to DNA and also
binds a zinc atom, the function of which is not known. P1 and P2 are phosphorylated soon after
their synthesis, but after binding to DNA most of the phosphate groups are removed and cysteine
residues are oxidized, forming disulfide bridges that link the protamines together. Both P1 and P2
have been shown to be required for normal sperm function in primates and many rodents.
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Gene organization and evolutionary history
Gene structure and chromosomal localization
Salmonid fish can have as many as 15 closely related
protamine genes per haploid genome, coding for as many as
six different proteins [1]. Birds carry two virtually identical
copies of the same gene per haploid genome [2], and only a
single copy each of the genes for protamines P1 and P2 have
been detected in mammals [3]. Even though it is likely that
the protamine P2 gene derives from a duplication of the
protamine P1 gene, the two proteins appear to be rapidly
diverging in amino-acid sequence.
The mammalian P1 and P2 genes contain a single intron
(Figure 1), whereas the protamine genes from birds (chicken
and quail) and salmonid fish are intronless. Detailed
alignments of the cis-acting regulatory sequences have
identified the presence of several consensus sequences.
These include conserved cAMP-response elements, the
TATA box, a CAP site, and a polyadenylation signal [4]. The
two chicken protamine genes are clustered together within
6 kb of each other. The genes for human P1 and P2 are
similarly co-located in a tight cluster on chromosome 16 at
16p13.2 [5]; this cluster also contains the gene for transition
protein-2, which is also involved in chromosome
condensation. A similarly arranged protamine cluster is
found on chromosome 16 in the mouse [3]. In human,
mouse, rat and bull the protamine cluster also contains an
open reading frame that has been referred to as ‘gene 4’ [6]
or ‘protamine 3’ [7]. The predicted amino-acid sequence for
this protein, which would be approximately the same size as
protamine P2, contains stretches of repeating glutamic and
aspartic acid residues similar in number and distribution to
the clusters of arginine and lysine residues found in the
DNA-binding domains of protamines. This difference in
composition (a high content of negatively charged amino
acids compared with the high content of positively chargedamino acids in protamines) suggests that the gene 4 protein,
which is not likely to bind to and condense DNA, may
instead bind to and interact with the protamines and
perform some other function related to chromatin
repackaging.
Whereas the protamine P1 gene (PRM1) appears to be trans-
cribed and translated in the spermatids of all mammals [8],
the protamine P2 gene (PRM2) is translationally regulated
in a species-specific manner. PCR amplification techniques
have confirmed the presence of PRM1 in a wide variety of
eutherian mammals, but attempts to amplify PRM2 and
hybridizations of PRM2 cDNA probes to genomic DNA have
revealed that PRM2 gene sequences exhibit considerable
divergence and may be less widely distributed phylo-
genetically [9-11]. All primates, and most rodents examined
so far, produce sperm that contain both P1 and P2 protamines
[12,13], showing that the P1 and P2 genes are both
transcribed and translated. The sperm of perissodactyls
(horse, zebra and tapir), lagomorphs (rabbit and hare) and
proboscids (elephants) have also been found to contain
processed protamine P2 and to use P2, in combination with
P1, to package their sperm genomes. The sperm of most
other species appear to contain only P1. In some of these
species (for example, bull and boar), the gene for protamine
P2 is present, but it seems to be dysfunctional or produce an
aberrant protein.
Evolution of protamines
Several excellent reviews describe the basic nuclear proteins
that package DNA in the sperm of plants [14] and animals
[15-20]. During sperm development in animals, the histones
that package DNA in early spermatids are removed from the
DNA and replaced in the final stages of spermatid matura-
tion by one of three types of proteins: sperm-specific histones,
protamine-like proteins or protamines. In mammals,
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Figure 1
Primary structures of mouse protamine genes and proteins. Schematic representation of the mouse (a) mP1 and (b) mP2 proteins. Numbers denote
amino acid residues; the two exons in each protein are shown on bars below the proteins; important residues are indicated as shown in the key (using
letters in the single-letter amino acid code, with a subscript number indicating the residue number). Ad, proposed DNA anchoring domains (regions
containing 3 or more consecutive arginine and lysine residues). Proposed phosphorylation sites are amino acid residues identified to be phosphorylated
in proteins isolated from sperm or following in vitro incubation of the isolated proteins of five mammalian species with cAMP-dependent protein kinase or
protein kinase C. 
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L 31 – S 32protamines do not replace the ‘somatic’ histones directly;
instead, the differentiating spermatids synthesize a group of
so-called transition proteins that bind to the spermatid DNA
in advance of the protamines. Comparative analyses of the
three families of proteins listed above suggest that the
process of preparing the sperm’s genome for fertilization
probably evolved from using specialized (sperm-specific)
histones to protamine-like proteins to protamines. This is
not to say, however, that the protamines of all animals are
closely related or structurally similar. Comparisons of the
amino-acid sequences of vertebrate and invertebrate
protamines show that the protamines from all animals do
not constitute a true family, and that the sequence, struc-
ture, and possibly function of protamines are evolving
independently in vertebrates and various invertebrate
groups (mollusks, cephalopods and tunicates).
Sperm-specific histones, which have been identified in
sperm from a wide range of species (from echinoderms to
primates),  are amino-acid sequence variants of somatic
histones. Among the best studied sperm-specific histones are
those from echinoderms (sea urchins), agnathans (lamprey
and hagfish) and sponges. In echinoderms, sperm contain
both somatic-type histones and specialized Sp H1 and Sp
H2B histone variants, which are believed to participate in
compacting the chromatin. These specialized histones are
synthesized just before meiosis, and they partially (in
echinoderms) or completely (in tunicates) replace their
somatic counterparts.
Protamine-like proteins have been found in the sperm of
many species, ranging from sponges to amphibians, and
comprise the most heterogeneous group of sperm basic
nuclear proteins. These proteins have a higher lysine and
arginine content (35-50% Arg and Lys) than histones, and
they are considerably larger (generally containing 100 to
more than 200 amino acids) than the proteins designated as
true protamines. The few protamine-like proteins that have
been analyzed in detail have structural features in common
with both histones and protamines. Like histone H1, these
proteins have a protease-resistant globular core and un-
structured carboxy- and amino-terminal domains enriched
in basic amino acids [21]. Post-translational cleavage of the
protamine-like proteins in mussel, cuttlefish and razor clam
yield small arginine- and lysine-rich fragments similar to
protamines. Sequence comparisons of the cleavage-
generated mussel protamine-like fragments and mammalian
protamine P1 show that the mussel fragments exhibit
significant similarity (around 50%) to mammalian protamines.
They differ, however, in that the majority of the positively
charged residues in the mussel sequence are lysine, rather
than arginine. One explanation for this difference comes
from sequence analyses of the sperm-specific H1 histones
and the protamines of sea squirts [22]. An analysis of codon
usage in the Ciona and  Styela protamine-like proteins
showed that the observed evolution could not be derived by
point mutations, but that a frameshift mutation in the
carboxy-terminal end of the lysine-rich sperm-specific H1
histone could lead to the arginine-rich sequence observed in
Styela protamine. Together, these observations provide
compelling support for the hypothesis that the protamines
evolved from H1-like histones [22-25].
The true protamines are typically short proteins (50-110
amino acids) that can contain up to 70% arginine. Gene and
protein sequences (see Additional data file 1) have been
determined for protamines from more than 100 vertebrate
species, and the true protamines are the best characterized
of the sperm basic nuclear proteins. Two structural elements
have been identified in all vertebrate protamines. One is a
series of small ‘anchoring’ domains containing multiple
arginine or lysine amino acids (three or more per domain,
highlighted in red in the figures in Additional data file 1) that
are used to bind the protein to DNA. The second is the
presence of multiple serine and threonine residues that can
be used as phosphorylation sites. The protamines of insects,
birds, teleost fish, reptiles and most marsupials lack
cysteine, whereas those present in eutherian mammals all
contain multiple cysteine residues that are oxidized to form
disulfide bridges that link the protamines together and
stabilize the chromatin complex during the final stages of
sperm maturation.
Two groups have independently reported evidence that
positive selection for the maintenance of a large number of
arginine residues (rather than selection at any particular
position) is being applied to protamine P1 in many species of
mammals [26,27]. The driving forces for this selection are
not known, but among those proposed, the more likely are
those that influence the stability of the sperm chromatin
complex. Protamines with a higher arginine content form
more stable complexes with DNA and are more efficient at
displacing histones and transition proteins from DNA. The
abundance of arginine has also been suggested to be
important for the subsequent remodeling of the sperm
chromatin complex following fertilization [28].
Characteristic structural features
Most of the structural information obtained for protamines
and DNA-protamine complexes has been derived from
protamines P1 and P2 of placental mammals, and from the
fish protamines salmine and clupine.
Protamine P1 and P1-like fish protamines
The P1 protamines of placental mammals are typically 49 or
50 amino acids long and contain three domains: a central
arginine-rich DNA-binding domain flanked on both sides by
short peptide segments containing cysteine residues. The
protamines of monotremes and most marsupials have
sequences similar to those of the placental mammals, except
that they lack cysteine residues. One genus of shrew-like
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to this generalization, as they have gained five or six cysteine
residues in their P1 protamines since their divergence from
the other dasyurids [29]. In most species, the central DNA-
binding  domain typically consists of a series of anchoring
sequences containing 3-11 consecutive arginine residues, which
bind the protein to DNA. This domain is similar in size and
composition to the entire sequence of many fish protamines
[30-33]. Sequence comparisons of the fish protamines with
mammalian P1 protamines show that the arginine-rich regions
containing the anchoring domains are conserved (around
60-80% sequence identity), but the remainder of the protein
sequence exhibits considerable variation.
Structural studies of the protamines and their complexes
with DNA have been limited primarily to bull P1 and
salmine. Raman spectroscopy has shown that the free
protamine is unstructured in solution [34]. Upon binding to
DNA, P1 wraps around the DNA helix in the major groove
(Figure 2a) [35], with one protamine molecule being bound
per turn of DNA helix [36]. Although not all the structural
details of the DNA-protamine complex have been resolved (a
crystallographic or nuclear magnetic resonance structure of
a DNA-protamine complex has not yet been obtained), the
predominant interactions that contribute to the remarkable
stability of the complex are the combination of hydrogen
bonds and electrostatic bonds that form between the
guanidinium groups of each arginine residue in the
anchoring domains of the protamine and the phosphate
groups in both DNA strands.
In contrast to the coiling of DNA by histones into
nucleosomes and the higher-order arrangements of nucleo-
somes in somatic chromatin, the binding of salmine or
protamine P1 induces the coiling and condensation of DNA
into much larger toroidal chromatin subunits [35,37]. These
toroidal subunits (Figure 2b,c), which have been observed in
native sperm chromatin [35] and have also been induced in
vitro by protamine binding to DNA [38], are approximately
50-70 nm in diameter, 25 nm thick and have been estimated
to contain approximately 50,000 bp of closely packed, coiled
DNA [39].
Protamine P2
While protamine P1 and P2 seem to have been derived from
a common ancestral precursor, P2 has several features that
distinguish it from P1. At the sequence level, P2 protamines
from different species exhibit the same variation as observed
in P1 protamines (over 60% sequence identity among P2
molecules; 50-70% sequence identity between P2 and P1
molecules). However, the gene PRM2 codes for a precursor
protein that has been shown to bind to DNA and then
undergo proteolytic processing. The processing event,
which has been examined in detail for mouse P2, occurs
over a period of several days in late-step spermatids and
results in the production of six partially processed forms of
the precursor [40,41]. When processing is complete,
approximately 40% of the amino terminus of the molecule
has been removed. The fully processed form of the P2
precursor, protamine P2, is slightly larger than P1 (63 amino
acids in mouse) and is the predominant form of P2 in the
mature sperm head.
Unlike in rodents and most other species of mammals, two
differently processed forms of protamine P2 - P2 and P3 -
are bound to DNA in human, ape and Old World monkey
sperm [12,42]. Only one processed form is observed in New
World monkeys. The two forms of the P2 protein differ only
in their three amino-terminal amino acids - P3 is three
amino acids shorter (at 54 amino-acid residues) than P2 (57
amino acids) - and they seem to be products of the same
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Figure 2
Protamine molecules bind in the major groove of DNA, neutralizing the
phosphodiester backbone of DNA and causing the DNA molecules to
coil into toroidal structures. (a) Model showing how two adjacent salmon
protamine molecules (blue atoms) wrap around the DNA helix (white
atoms) and bind within the major groove of DNA. (b) Scanning-probe
images of toroidal DNA-protamine complexes prepared in vitro on a
graphite surface by adding protamine to DNA attached loosely to the
surface. The toroids formed in vitro are similar in size and shape to those
isolated from human sperm chromatin (c). (c) Scanning-probe
microscope images of native DNA-protamine toroids obtained from
human sperm chromatin. These toroids, which comprise the basic subunit
structure of protamine-bound DNA, contain approximately 50,000 bp of
DNA coiled into each donut-shaped structure. PRM2 gene. A third protamine P2 sequence variant has also
been detected in human [42] and macaque [12] sperm.
Protamine P2 also differs from P1 in that P2 binds zinc.
Physical measurements performed on intact sperm from
different species show that the P2 protamines from human,
mouse and hamster coordinate one zinc atom per molecule
[43]. Different zinc-finger models have been proposed for
the zinc coordination site(s) in human P2 [44,45]. However,
none of these models is consistent with the conserved histi-
dine and cysteine residues present in the majority of known
P2 protamines. These models also require the majority of the
protamine P2 sequence to wrap around and coordinate zinc.
Such structures would not be expected to bind to the length
of DNA sequence that has been estimated to be the P2
protamine footprint [36]. In stallion spermatids, zinc
appears to play an integral role in sperm chromatin matura-
tion [46]. A significant fraction of the zinc is lost from sperm
chromatin when the cysteine thiols in protamine are
oxidized into disulfide bonds. More recent X-ray absorption
fine-structure studies of the zinc bound to protamine in
intact elongating hamster spermatids and epididymal sperm
(C Dolan, K Peariso, M Corzett, J Mazrimas, J Pennerhahn
and RB, unpublished observations) suggest that the amino-
acid residues involved in the coordination are located near
the carboxy-terminal end of protamine P2 and the residues
involved in the coordination change when the intra- and
inter-protamine disulfide crosslinks form.
Localization and function
Subcellular distribution and tissue expression patterns
The protamines are synthesized in soluble polyribosomes in
the cytoplasm of elongating spermatids [47], and they bind
to and package all but a very small subset of the sperm
genome. One notable exception is human sperm. In humans,
and possibly other primates, a significant fraction (10-15%)
of the sperm’s genome is packaged by histones. These
histones, many of which are variants of their somatic histone
counterparts, package the DNA into nucleosomes that are
more closely packed than in somatic chromatin [48]. This is
surprising considering the absence of histone H1, the
extensive acetylation of histones H3 and H4, and the
phosphorylation of the H2aX histone variant in these
nucleosomes. Although most of the genes that retain their
histone packaging in human sperm have not yet been
identified, they do seem to represent a unique subset of the
sperm genome [49,50]. DNA that has been identified as
packaged by histones in mature sperm includes the genes for
ε-globin and γ-globin [51] and telomeric DNA [52].
Biochemical analyses [53] and immunohistochemical
staining using protamine-specific antibodies [54] of the
various stages of spermiogenic cells have shown that the
protamines first appear in elongating spermatids, coincident
with the initiation of the final stage of chromatin
condensation. Transcription and translation of protamine
mRNAs has been shown to occur in specific spermatid stages
[55,56], and protamine mRNA has not been detected in
Sertoli or interstitial cells or in other tissues [57,58]. There is
also no clear biochemical evidence demonstrating the presence
of protamines in other cells or tissues. The UniGene
database reports numerous expressed sequence tags (ESTs)
for PRM1 and PRM2 in some human non-testis or germ-cell
cDNA libraries, including fetal brain, kidney and placenta.
At present, however, it is not clear whether these ESTs are
artifacts or the result of ectopic expression, or whether they
indicate biologically relevant expression of protamine
mRNAs or proteins in non-sperm cells.
Post-translational modifications
In mammalian P1 protamines, the DNA-binding domain and
the amino-terminal peptide sequence flanking the DNA-
binding domain typically contain one or more phosphory-
lation sites. These sites, which have been identified in human,
stallion and bull P1, seem to be phosphorylated immediately
after the protein is synthesized and again following the
sperm’s entrance into the egg. The unprocessed form of the
P2 precursor, as well as various processed forms, are also
phosphorylated [59]. The predominant phosphorylation sites
involve serine and threonine, although tyrosine residues have
also been found to be phosphorylated in rat protamine [60].
The function of protamine phosphorylation has not yet been
determined, but it has been proposed that the addition of
phosphates to specific serine residues may prevent these
regions from interacting with DNA.
The only other known post-translational modifications of
protamines are the disulfide bonds that form during the final
stages of sperm maturation and epididymal transit in
eutherian mammals. After binding of the P1 protamines to
DNA, the thiol groups of the cysteines located in the amino-
and carboxy-terminal domains of P1 form both intra- and
inter-protamine disulfide bonds [37]. These covalent cross-
links interlock neighboring protamine molecules together
and prevent their removal or dissociation from DNA until
the disulfides are reduced after the sperm enters the egg.
Protamine P2 is also post-translationally modified through
the production of inter-protamine disulfide bonds. Which
protamine P2 cysteine residues participate in the formation
of the disulfide crosslinks and how many disulfides are
formed are not known.
Protamine functions
Several possible functions have been proposed for protamines
but only one has been unequivocally demonstrated. The
synthesis and deposition of protamine in spermatid
chromatin has been shown to correlate temporally with the
condensation of the genome of the elongating spermatid and
the concomitant termination of transcription [61]. Each
protamine P1 molecule binds to 10-11 bp of DNA; protamine
P2 binds to a slightly larger segment of DNA (around 15 bp).
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phosphodiester backbone of DNA and enables adjacent DNA
molecules to pack close together. In the sperm of eutherian
mammals, the DNA-bound protamines are finally locked
into place during epididymal transit by the formation of a
network of disulfide bonds. The inactivation of the majority
of the spermatid’s genes paves the way for the reprogram-
ming of the male genome and the initiation of embryonic
development. It also ensures that the male genome does not
begin functioning as a testicular cell once it fertilizes the egg.
Although it is generally accepted that sperm chromatin
condensation does not play a direct role in the shaping of the
sperm head, protamine binding to DNA does result in the
production of an uncharged chromatin complex that enables
the DNA molecules to be condensed into a volume some
1/20th that of a somatic nucleus. This condensation enables
the production of a smaller, more hydrodynamic head, and
contributes, albeit indirectly, to head shape. This is
consistent with the observation that sperm containing
improperly packaged chromatin frequently have enlarged or
abnormal head shapes [62].
What little we currently know about the interrelationships
between P1 and P2, chromatin organization and male
fertility has been obtained from studies of mammalian sperm,
primarily from transgenic mice, and from in vitro studies of
sperm injected into oocytes. Gene knockout experiments
have provided convincing evidence that the presence of both
P1 and P2 is required for proper spermatid maturation and
male fertility in the mouse [63]. In addition, maintaining the
correct proportion of the two protamines in mice has been
shown to be critical for maintaining the integrity of the
sperm chromatin. Mouse sperm deficient in protamine P2
have increased DNA damage, incomplete chromatin conden-
sation and other defects that block embryonic development
beyond the blastocyst stage [64]. Other studies have
suggested that incomplete processing of the P2 precursor
could also have an impact on sperm function and could
contribute to male infertility in both mouse and man [65-70].
These and numerous other studies of human sperm that vary
in their content of P1 and P2 have begun to provide
compelling evidence that alterations in the composition of
sperm chromatin and its structural organization (to which
P1 and P2 contribute) may affect both fertilization and early
events in embryonic development [71]. Intracytoplasmic
injection of human sperm that lack the proper amounts of
protamines P1 and P2 into human oocytes have revealed that
many of these sperm decondense prematurely in the oocyte
[72,73], which results in failed fertilization. Comparisons of
the rates of decondensation of sperm from five mammal
species with different natural protamine P1/P2 ratios
injected into hamster oocytes have suggested one possible
explanation - that the protamine P2 content of sperm may
regulate the rate at which sperm chromatin decondenses and
the male genome is reactivated following fertilization [74].
Sperm containing a higher proportion of P2 (for example,
human and hamster) were observed to decondense more
quickly in oocytes than sperm containing very little (for
example, rat) or no (for example, bull) P2. Because the
progression of development beyond the initial fertilization
event in mammals requires the sperm cell to complete the
decondensation process within a particular period of time
after entering the oocyte, and this time varies among species,
differences in the P2 content of sperm chromatin may
provide a mechanism for ‘bar-coding’ an incoming genome
and identifying it as acceptable or not. This is consistent
with the observation that the P2 content and the P1/P2 ratio
of sperm chromatin seem to be tightly regulated within a
species [75] but vary dramatically between species. It might
also explain why human males that produce sperm
containing abnormal proportions of P1 and P2 are infertile.
Frontiers
The information that has been obtained about the protamine
family of DNA-binding proteins during the past two decades
is beginning to have an impact on several very different
areas of future research in reproductive biology, evolutionary
biology, gene therapy and nanotechnology. An increasing
number of biochemical studies of sperm produced by
infertile males and transgenic animals have provided
evidence that changes in the protamine content of sperm
chromatin, incomplete protamine P2 precursor processing,
alterations in the P1/P2 ratio or deficiencies in zinc (or
replacement of zinc by other metals) may contribute to male
infertility. Exposure of males to certain alkylating agents has
also been reported to have an adverse impact on repro-
duction by modifying cysteine residues in protamines and
inducing dominant lethal mutations. This information,
together with our present knowledge of protamine structure
and function and advances in transgene technology, make it
possible to test directly how specific changes in protamine
structure (for example, the removal of phosphorylation sites,
changes in P2 processing sites or removal of functional thiols
and zinc-coordinating residues) and sperm chromatin
composition impact on protamine function, chromatin
packaging, male fertility and the progression of early
embryogenesis. We have also learned enough about how
protamine functions to create small synthetic DNA-binding
proteins or peptides for use in packaging, protecting and
aiding the delivery of functional genes to selected cell
populations for use in gene therapy [76-78], gene silencing
[79] or in targeting toxic genes to tumor cells [80]. The self-
assembling nature of the protamine-DNA complex may also
provide a new approach that can be used to create
nanometer- to micrometer-scale self-assembling electrically
conductive polymers for use in constructing biocompatible
electrical circuits.
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Additional data is available online with this article.
Additional data file 1 contains a figure showing the
amino-acid sequence alignments (using ClustalW [81]) for
protamines  (a) P1 and (b) P2. The ‘anchoring’ domains
containing multiple arginine or lysine amino acids are
highlighted in red.
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